Burning Rock Biotech Limited Share Price
NASDAQ: BNRBurning Rock Biotech Limited Stock Performance
Burning Rock Biotech Limited Share Price Chart
Burning Rock Biotech Limited Annual Profit & Loss
All figures in USD
About Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Burning Rock Biotech Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $16.10 | $14.80 | -21.05% |
Sep 2026 | $9.43 | $18.75 | +105.09% |
Aug 2026 | $10.87 | $9.14 | -16.76% |
Jul 2026 | $10.07 | $10.98 | +36.23% |
Jun 2026 | $8.93 | $8.06 | -33.00% |
May 2026 | $17.09 | $12.03 | -27.38% |
Apr 2026 | $16.89 | $16.57 | +1.63% |
Mar 2026 | $21.16 | $16.30 | -33.25% |
Feb 2026 | $35.61 | $24.42 | -27.61% |
Jan 2026 | $20.00 | $33.73 | +64.60% |
Dec 2025 | $22.12 | $20.50 | -4.85% |
Nov 2025 | $13.18 | $21.54 | +69.07% |